Keyword: Pfizer

News

Entering the Age of the $1 Million Medicine

03.01.2013 - The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...

News

US FDA New Drug Approvals Hit 16-Year High in 2012

02.01.2013 - U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...

News

FDA Approves Bristol Myers, Pfizer's Anti-Clotting Drug Eliquis

29.12.2012 - U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb and Pfizer, for treatment in patients with atrial fibrillation, or irregular...

News

Mitsubishi Chem to Buy Capsule Maker from Carlyle

25.12.2012 - Japan's Mitsubishi Chemical Holdings Corp will acquire Qualicaps from U.S.-based Carlyle Group, a person familiar with the matter said on Tuesday, rewarding the buyout firm's...

News

Eli Lilly to Pay $29 Million to Settle US SEC Bribery Case

21.12.2012 - U.S. drugmaker Eli Lilly agreed on Thursday to pay $29 million to settle civil charges that its subsidiaries made improper payments to foreign government officials to win business...

News

Drug Industry Treading Water on R&D Productivity

04.12.2012 - Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...

News

Ranbaxy Halts Generic Lipitor Production After Recall

30.11.2012 - Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent...

News

Canada's Supreme Court Strips Viagra Patent from Pfizer

09.11.2012 - Canada's Supreme Court struck down the patent on global pharmaceuticals giant Pfizer's Viagra erectile dysfunction drug on Thursday and opened the door to generic competition. The...